Authors: Rachel Knevel, Saskia le Cessie, Chikashi C. Terao, Kamil Slowikowski, Jing Cui, Tom W. J. Huizinga, Karen H. Costenbader, Katherine P. Liao, Elizabeth W. Karlson, Soumya Raychaudhuri
Published: 2020-05-27
DOI: 10.1126/scitranslmed.aay1548
Source: Full article
A genetic risk tool could be used at the first clinical visit of patients with inflammatory arthritis to increase diagnostic efficacy.